The diagnosis of oligosarcoma can be established by the combination of an IDH-mutant tumor with at least partial (leiomyo)sarcomatous differentiation which harbors a 1p/19q LOH which may be copy number neutral and typically (but not always) a TERT promoter mutation. Here, IDH2 is linked to neoplasm.